Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19047,154,1.87 [1.18-2.97],0.0082620842661315
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",20027,207,1.04 [0.65-1.67],0.8558903172120498
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19795,1443,1.39 [1.17-1.64],0.0001686374763018
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,20039,458,1.40 [1.03-1.89],0.0307736157849386
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19392,3538,1.17 [1.04-1.31],0.0069933217587515
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19357,3583,1.29 [1.15-1.44],7.649501929683323e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19791,1192,1.09 [0.90-1.33],0.3753760653050932
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19955,112,0.98 [0.52-1.87],0.960258381146098
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17685,1055,1.44 [1.18-1.76],0.0002869786150951
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17039,1266,1.46 [1.22-1.75],3.795588851903075e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16688,276,1.61 [1.10-2.35],0.0133007318657109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13076,2273,1.30 [1.13-1.50],0.0001838366935894
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16636,406,1.51 [1.10-2.07],0.0105697950865198
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,20009,1410,1.10 [0.92-1.32],0.2868547069894012
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Mycoses,20112,531,1.35 [1.02-1.79],0.0376756394179571
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19368,1016,1.31 [1.06-1.60],0.0108179384446443
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20059,1166,1.50 [1.25-1.81],1.3755083730800443e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18806,207,1.06 [0.66-1.69],0.8161256722308055
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20163,52,0.96 [0.37-2.49],0.9380784947455588
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19909,1016,1.46 [1.19-1.78],0.0002149825412203
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19906,63,1.00 [0.43-2.32],0.9999590929569367
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20108,115,1.17 [0.63-2.18],0.6236528341816235
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20093,100,1.20 [0.62-2.33],0.5913063761612876
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18744,392,1.67 [1.23-2.28],0.001139005854395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18610,258,1.02 [0.67-1.56],0.91773648527494
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18703,104,1.23 [0.64-2.35],0.5350721860697871
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20148,48,1.37 [0.53-3.54],0.5184345894863606
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20103,154,1.53 [0.91-2.55],0.1061258592493347
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral warts,19999,50,1.42 [0.56-3.58],0.461982912608363
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],20022,73,1.67 [0.81-3.44],0.1619217393944637
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm,19913,230,0.80 [0.51-1.25],0.3250340148342505
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20089,39,0.79 [0.26-2.40],0.6735953798929724
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20072,41,0.60 [0.20-1.74],0.3452330321772384
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9537,71,1.29 [0.58-2.85],0.5364876078574171
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19766,1452,0.84 [0.71-1.01],0.0665618977523126
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of meninges,20149,56,0.82 [0.32-2.07],0.6692004100233446
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20081,70,0.88 [0.39-2.00],0.7664417658443439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20139,103,1.06 [0.55-2.06],0.8613778118742561
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of ovary,10575,65,0.30 [0.12-0.74],0.0084968941883464
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20128,392,0.87 [0.62-1.23],0.4401781107961898
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Caecum,20140,334,0.81 [0.56-1.19],0.2865419514542465
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20038,73,0.77 [0.34-1.71],0.5151666566130637
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,20127,225,0.74 [0.47-1.18],0.2083932430007471
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Rectum,20084,359,0.90 [0.63-1.29],0.5697748123703581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,20026,604,1.00 [0.76-1.31],0.9870419997436432
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20119,462,1.00 [0.73-1.37],0.992745190946837
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Carcinoma in situ of breast,7948,45,0.86 [0.31-2.35],0.770589329007208
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7981,55,0.93 [0.37-2.33],0.8817797108385805
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14431,63,2.40 [1.28-4.50],0.0062240420381768
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14451,83,1.20 [0.58-2.48],0.6281049312664582
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20110,110,1.18 [0.62-2.23],0.6190965058024513
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma, any site",20111,107,1.12 [0.58-2.15],0.7291221713705911
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Leiomyoma of uterus,10334,150,1.35 [0.78-2.31],0.2794342281593346
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lung cancer and mesothelioma,12855,436,1.77 [1.22-2.56],0.0026257741507254
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lymphoid leukaemia,14433,65,2.52 [1.39-4.56],0.0023239588066955
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14561,193,1.00 [0.61-1.63],0.9983250638585928
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14631,263,1.09 [0.73-1.65],0.671055488354937
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",8064,99,1.01 [0.52-1.98],0.9686924684973586
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14466,98,0.78 [0.39-1.56],0.4823950866678913
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14492,124,0.78 [0.42-1.44],0.4238659153992646
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14479,111,1.22 [0.66-2.26],0.5300264111777487
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8046,81,1.77 [0.92-3.42],0.087185177300175
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14478,110,0.58 [0.30-1.13],0.1099106015563135
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7231,828,0.88 [0.69-1.11],0.2887231517343523
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14484,116,0.86 [0.46-1.63],0.6461239933708842
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14449,81,1.38 [0.68-2.79],0.3696445277039527
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14489,121,1.54 [0.88-2.73],0.1332507385702776
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi,20037,163,0.65 [0.37-1.12],0.1224269784582815
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi of trunk,20138,67,0.62 [0.26-1.45],0.2696593993838414
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanoma in situ,14415,100,0.95 [0.48-1.88],0.875511469195062
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14472,104,1.69 [0.94-3.01],0.0771879707909863
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14542,174,1.40 [0.87-2.26],0.1686921998934019
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14670,302,1.36 [0.95-1.95],0.0919714471786978
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14482,114,1.30 [0.72-2.37],0.3862974560814485
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Other benign neoplasms of skin,20012,148,1.03 [0.59-1.80],0.922973956840124
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15646,1278,1.07 [0.89-1.29],0.4786426805373484
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15714,1346,1.08 [0.90-1.30],0.3900429744966501
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19901,329,1.54 [1.09-2.18],0.015087673490428
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18226,111,1.25 [0.66-2.35],0.4885403149779058
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19635,63,1.66 [0.78-3.56],0.1893525296466112
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19545,2948,1.04 [0.91-1.18],0.5724789077138039
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18739,62,1.24 [0.55-2.81],0.6102470604991495
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19766,59,0.66 [0.27-1.64],0.3740216979596454
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19754,1639,1.14 [0.96-1.34],0.1336694815244108
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19752,1637,1.14 [0.96-1.34],0.1351258478864939
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18212,97,1.77 [0.95-3.28],0.0699163020819964
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19861,1184,0.97 [0.79-1.18],0.7460739374490066
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19809,102,1.49 [0.80-2.78],0.2067606592091503
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19632,60,1.62 [0.74-3.54],0.2284859893512935
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19642,70,1.54 [0.72-3.30],0.2645800394696755
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,20004,297,1.36 [0.93-1.97],0.1113823356681901
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20054,32,0.82 [0.24-2.77],0.7473572902187176
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19949,242,1.51 [1.00-2.25],0.0473897149880739
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18791,114,0.49 [0.26-0.95],0.0350571832760853
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13656,342,1.28 [0.90-1.81],0.1739796093560321
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18869,88,1.40 [0.67-2.91],0.3741753523921557
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18877,96,0.95 [0.47-1.92],0.8943160345239668
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13374,60,2.54 [1.37-4.74],0.0032639785357243
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18776,44,1.98 [0.80-4.89],0.1384607257794456
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18140,273,0.93 [0.62-1.41],0.7421014305957372
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19513,767,1.28 [1.01-1.62],0.0373992201891247
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19160,414,1.22 [0.88-1.69],0.2359894852987661
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18895,149,0.90 [0.51-1.58],0.7045200058480139
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19935,1203,0.85 [0.69-1.03],0.1029298085094128
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17073,1173,0.85 [0.69-1.04],0.1116219859110193
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13383,69,1.52 [0.71-3.25],0.2793838149766064
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",18217,86,1.07 [0.51-2.23],0.8544302025918353
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13623,309,1.23 [0.84-1.79],0.2896696633990666
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13364,50,1.65 [0.71-3.84],0.2466845211357655
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17247,3933,1.09 [0.98-1.21],0.11531084118133
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13548,234,1.70 [1.15-2.51],0.0073555882524657
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13920,606,1.44 [1.11-1.85],0.0057694630070787
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20114,308,1.29 [0.89-1.88],0.1778157267905577
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19929,123,1.67 [0.97-2.87],0.0646277523529517
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13443,129,1.97 [1.23-3.16],0.0049921228411185
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13383,69,0.93 [0.41-2.11],0.8678637056319254
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19615,1484,1.09 [0.91-1.30],0.3544668572823286
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13626,312,1.93 [1.43-2.61],1.8549432790170463e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13640,326,1.17 [0.82-1.68],0.3925851087199186
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14046,732,1.05 [0.82-1.35],0.7017475378173281
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13446,132,1.39 [0.81-2.38],0.237726973734313
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19924,118,1.64 [0.94-2.85],0.0816745109412174
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14074,760,1.50 [1.20-1.89],0.0004710760985169
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13871,557,1.47 [1.13-1.92],0.0043681104908084
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17927,60,1.91 [0.91-4.02],0.088631745206501
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18832,5518,1.17 [1.07-1.27],0.0008445308446675
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,18181,50,0.48 [0.18-1.28],0.1401597069325083
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,18178,47,0.73 [0.26-2.04],0.549315545650344
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20015,1600,0.94 [0.80-1.11],0.4544390153818037
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20013,1598,0.94 [0.79-1.10],0.4345593982686415
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,18184,53,0.97 [0.38-2.51],0.9543514614295427
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19857,983,1.06 [0.85-1.32],0.6045393901887228
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15189,1875,1.37 [1.18-1.59],2.74883809823664e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20152,251,1.78 [1.23-2.57],0.0023863768066651
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18843,97,0.82 [0.41-1.64],0.5700881925987054
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18977,103,0.97 [0.50-1.91],0.935727168341558
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19019,145,0.63 [0.35-1.13],0.1245286102209784
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13478,164,0.86 [0.50-1.49],0.5932411744733227
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17770,157,1.68 [1.05-2.69],0.0314269194037874
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2138,84,1.68 [0.86-3.27],0.1274229630258337
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2273,252,1.01 [0.67-1.52],0.978941722403224
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17683,70,1.62 [0.80-3.26],0.1794991344197806
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2104,51,0.81 [0.32-2.06],0.6631172616212249
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19462,1849,1.16 [1.00-1.35],0.0551485277119332
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19255,509,1.02 [0.75-1.38],0.9046111463455744
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18242,375,1.15 [0.82-1.63],0.4144792443081422
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14229,915,1.23 [0.99-1.52],0.0645239099068838
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20045,265,1.95 [1.35-2.82],0.0003635940770613
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18908,231,1.23 [0.79-1.89],0.3564965737874243
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Angina pectoris,17475,1311,1.16 [0.96-1.39],0.1189026015272994
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18998,321,1.26 [0.87-1.83],0.212635463683977
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18747,70,2.08 [1.05-4.12],0.0368591389932234
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18917,240,2.21 [1.56-3.12],7.176029708410326e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10302,2419,1.49 [1.29-1.72],3.734192672940718e-08
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,AV-block,15434,561,1.12 [0.84-1.49],0.4356549133357124
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20092,479,1.19 [0.88-1.61],0.2653197960856661
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,8110,227,1.88 [1.18-3.01],0.0083920308669539
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15049,176,1.66 [1.04-2.66],0.0337086622485398
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14964,91,1.35 [0.67-2.71],0.4064744535183336
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20158,63,1.67 [0.78-3.58],0.1850237950457028
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Conduction disorders,16179,1306,1.16 [0.96-1.40],0.1240313315658821
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18504,2362,1.16 [1.01-1.33],0.0351104807408935
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16332,7751,1.08 [1.00-1.17],0.040992451377811
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18820,291,2.01 [1.40-2.88],0.0001540540879102
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Endocarditis,14949,76,2.50 [1.51-4.14],0.0003486411709866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19914,1401,1.65 [1.41-1.94],1.07157808387365e-09
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertension,17395,6853,1.05 [0.97-1.14],0.2169111451765051
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17399,6857,1.05 [0.97-1.14],0.2130942760627495
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",20017,86,2.28 [1.34-3.88],0.0024690632350226
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10783,241,3.16 [2.51-4.00],3.944172519707484e-22
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10669,127,1.69 [1.03-2.76],0.0361068178921574
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypotension,20008,1334,1.36 [1.14-1.63],0.0006837554329597
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19074,123,1.06 [0.58-1.96],0.845006817107725
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18654,2490,1.15 [1.01-1.31],0.0394014968177615
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19739,681,1.15 [0.89-1.48],0.2853124044789233
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15306,433,1.43 [1.05-1.96],0.0226900463292623
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19594,904,1.05 [0.84-1.32],0.6582882794517453
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16940,776,1.06 [0.83-1.35],0.6425349565009042
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20049,167,1.12 [0.67-1.88],0.6679020719962563
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20124,347,1.09 [0.76-1.57],0.6297329388022515
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,18589,60,2.00 [0.85-4.68],0.1098872100244771
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other aneurysm,18762,85,2.38 [1.36-4.16],0.0022528229635169
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,15377,504,1.42 [1.06-1.90],0.0173124031533395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18787,110,1.92 [1.08-3.42],0.0252364901715093
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18950,273,1.52 [1.02-2.25],0.0395468467438573
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15066,193,1.37 [0.86-2.19],0.1906017531105435
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,18617,88,2.60 [1.37-4.95],0.003600086636447
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18568,39,0.43 [0.14-1.30],0.1343775185902668
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18437,76,0.83 [0.38-1.82],0.64923073541272
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18674,145,1.80 [1.05-3.09],0.0322800277880346
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16080,1207,1.56 [1.31-1.87],1.1484021630317576e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18725,51,1.54 [0.65-3.68],0.3271249456420969
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19289,612,1.53 [1.18-1.99],0.0014637882556715
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19503,468,2.89 [2.37-3.52],1.49426299698189e-25
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19178,817,1.05 [0.83-1.32],0.7129267237750078
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8234,351,2.00 [1.39-2.87],0.000169163108907
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19140,495,1.77 [1.34-2.32],4.591039400196512e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18892,363,1.80 [1.29-2.52],0.0005336920196266
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19541,506,1.28 [0.95-1.72],0.1021870118315505
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20073,818,1.54 [1.24-1.92],0.0001010795012427
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15313,440,1.11 [0.80-1.53],0.543725935974086
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19498,463,2.86 [2.34-3.50],1.5406280338937912e-24
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18576,215,1.27 [0.82-1.98],0.2897693002068875
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19722,771,1.16 [0.92-1.48],0.2140454576596533
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19710,804,1.19 [0.94-1.51],0.1403240188991586
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19048,51,1.97 [0.89-4.38],0.0942381726606926
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18762,85,1.67 [0.85-3.30],0.1375048621534307
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19325,267,1.14 [0.76-1.72],0.5322294151914948
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18971,281,1.11 [0.74-1.64],0.6182596648236945
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Varicose veins,18967,438,1.49 [1.08-2.06],0.0150750056567321
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18692,100,1.11 [0.55-2.23],0.7666615901607239
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19919,800,1.47 [1.16-1.85],0.0011830395845611
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20094,289,1.19 [0.80-1.76],0.3970121757119211
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17332,1196,0.95 [0.78-1.16],0.599700924336796
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Any mental disorder,19719,3583,1.01 [0.90-1.13],0.8693032999800336
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",20068,340,1.09 [0.76-1.58],0.6319085496390991
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17360,1224,0.87 [0.72-1.07],0.1843103723892063
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16200,64,1.10 [0.48-2.53],0.827074234657206
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Smoking dependency,19721,1006,1.24 [1.01-1.52],0.0428232069563508
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17380,1244,1.15 [0.96-1.40],0.1372906134082692
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Vascular dementia,19440,197,1.10 [0.68-1.77],0.6904912737256276
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Alzheimer disease,20160,510,1.14 [0.84-1.53],0.3965006032627414
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12570,96,1.62 [0.91-2.88],0.1000407073237776
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Bell's palsy,18583,72,1.12 [0.51-2.46],0.7849143720803087
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18943,432,0.96 [0.69-1.34],0.8301940869697391
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral cysts,19785,206,1.14 [0.71-1.83],0.5782961343027105
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20097,330,1.33 [0.93-1.90],0.1148851782233327
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19454,73,0.82 [0.36-1.85],0.632803788838322
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20144,61,1.10 [0.47-2.58],0.8249798126739303
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19648,69,2.27 [1.19-4.32],0.0126043934258086
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Epilepsy,18894,252,1.40 [0.93-2.12],0.1088750416318409
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19773,1131,1.29 [1.06-1.57],0.0098065308828441
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20111,543,0.93 [0.69-1.25],0.6435344032577549
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19591,2885,1.12 [0.99-1.27],0.0706190787431909
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,19848,45,2.49 [1.16-5.34],0.0195871136385039
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hemiplegia,20035,268,1.25 [0.83-1.86],0.2810351109443703
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hydrocephalus,19638,59,1.90 [0.87-4.18],0.1079596499264286
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20148,58,1.77 [0.79-3.94],0.1651489234121706
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18573,62,1.17 [0.49-2.76],0.7277234296042793
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18575,64,0.82 [0.35-1.93],0.653923493654249
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Memory loss,19225,133,1.12 [0.62-2.01],0.7095150066992343
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Migraine,18879,237,1.26 [0.82-1.96],0.2949423145954293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20117,216,1.44 [0.93-2.25],0.1052493903385622
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Motor neuron disease,12661,166,1.05 [0.62-1.80],0.8489730629748097
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20051,52,1.35 [0.54-3.37],0.5272296592185375
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19557,1046,0.98 [0.79-1.21],0.8489159431555879
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Neurological diseases,18895,3572,1.08 [0.96-1.21],0.1911922755212627
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19628,247,1.12 [0.73-1.71],0.6051333858527663
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18853,342,0.87 [0.60-1.27],0.4824933658883715
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20092,290,2.52 [1.89-3.36],2.699241491744885e-10
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15302,820,1.20 [0.95-1.51],0.1324443131940785
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19649,70,0.65 [0.29-1.48],0.307185139575459
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19713,134,1.20 [0.68-2.13],0.521641988713115
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19747,179,1.17 [0.71-1.94],0.5407069496726913
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18590,79,1.03 [0.48-2.22],0.930269303593173
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other headache syndromes,18689,47,1.39 [0.54-3.57],0.4913406134340898
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other neurological diseases,20063,484,1.14 [0.84-1.54],0.4097210288344837
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other sleep disorders,19068,426,1.38 [1.03-1.87],0.0330904883638797
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Parkinson's disease,20129,345,0.83 [0.57-1.21],0.3273589595897904
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19618,39,0.71 [0.40-1.26],0.2420722730273505
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,20159,78,1.15 [0.53-2.48],0.7181906359671932
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Sleep apnoea,19970,367,1.39 [1.01-1.91],0.0444236402196434
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19854,52,3.72 [2.27-6.11],2.043353796273932e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20148,187,1.33 [0.82-2.16],0.2519007662637152
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18574,63,0.77 [0.32-1.85],0.5540692135552959
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20160,515,1.13 [0.84-1.52],0.4138875123094874
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19384,191,1.08 [0.66-1.75],0.7652505548270301
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19617,130,1.21 [0.67-2.18],0.5285365926809066
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19783,490,1.17 [0.86-1.58],0.3172008326226696
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19956,223,1.16 [0.75-1.78],0.5144571636645505
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19098,57,1.50 [0.64-3.51],0.3454205523383274
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19077,36,2.09 [0.81-5.41],0.1284925538834046
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20055,64,1.56 [0.71-3.41],0.2673851634863171
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19885,197,0.89 [0.55-1.46],0.6522078720943909
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2108,54,1.04 [0.42-2.53],0.9393808907604912
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2590,96,1.84 [1.02-3.31],0.0411074441124163
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19579,92,1.55 [0.80-2.99],0.1962409186668893
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19922,1227,1.01 [0.83-1.22],0.9256241467722846
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19802,761,1.06 [0.83-1.36],0.6324205078260627
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19302,261,1.01 [0.66-1.54],0.9715712705212132
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20104,811,1.22 [0.97-1.55],0.0907702017873928
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20154,69,0.98 [0.43-2.23],0.953542103702134
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20051,758,1.16 [0.91-1.48],0.2377284994248334
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20125,437,1.09 [0.79-1.50],0.6133251996482485
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20054,196,1.08 [0.67-1.75],0.7571046951547684
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19130,89,0.62 [0.30-1.29],0.201933247204315
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19131,90,1.59 [0.82-3.06],0.1699390996885016
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19108,67,0.72 [0.31-1.69],0.451361079786914
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20043,871,1.13 [0.90-1.42],0.3061222943621855
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19410,238,0.99 [0.63-1.54],0.9557951683186128
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19353,60,1.06 [0.44-2.54],0.8953814843894012
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19797,109,1.73 [0.97-3.10],0.0632152283629321
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,20027,339,1.00 [0.69-1.44],0.9798949561970972
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19479,186,1.22 [0.74-1.99],0.4342248709119579
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19978,120,1.09 [0.59-2.02],0.7843235270178752
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19739,567,1.23 [0.93-1.62],0.1516592374578006
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19625,138,1.57 [0.92-2.68],0.1015028887784693
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18060,2812,1.05 [0.93-1.20],0.4244918330934423
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19990,302,0.93 [0.62-1.38],0.7086290895607488
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20146,164,1.20 [0.72-2.02],0.4876277140201944
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19507,466,1.03 [0.75-1.41],0.8418559716050253
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19768,80,1.73 [0.89-3.38],0.1081285883555607
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20146,61,1.06 [0.44-2.55],0.8905627567732719
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19152,111,1.22 [0.64-2.30],0.5464712672793848
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19195,154,0.73 [0.42-1.29],0.2774681583093541
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18838,143,1.36 [0.80-2.34],0.2593048495214007
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19340,47,2.79 [1.41-5.52],0.0031165770657028
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18761,66,1.38 [0.61-3.15],0.4406449168902153
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19272,100,0.73 [0.37-1.47],0.3856603908310292
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19420,248,0.96 [0.62-1.49],0.8640452368967264
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19170,129,1.46 [0.83-2.56],0.1872665783568377
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18777,82,1.09 [0.51-2.32],0.8267046570147849
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18803,108,0.80 [0.41-1.55],0.5045220034584097
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17584,2336,1.15 [1.00-1.32],0.0435421455127573
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19123,82,1.31 [0.63-2.71],0.4693882457628863
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19916,429,1.33 [0.97-1.83],0.0760594549154587
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19554,67,0.70 [0.30-1.63],0.411285870042567
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19653,166,1.22 [0.73-2.04],0.4535201408965317
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19956,98,0.82 [0.41-1.66],0.5810834301195069
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20123,119,0.97 [0.52-1.81],0.9245779656384218
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20045,100,1.67 [0.90-3.08],0.1022604009695251
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19918,60,1.84 [0.84-4.01],0.1267250424801745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19920,62,0.92 [0.38-2.20],0.846666913813602
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20063,1029,1.10 [0.89-1.35],0.3875373425808587
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19813,779,1.05 [0.83-1.34],0.6753446166800354
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19162,128,0.99 [0.54-1.80],0.9701344396115388
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19112,78,1.36 [0.66-2.84],0.4059254012781126
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,19988,54,0.80 [0.31-2.05],0.6393386819776216
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20092,158,1.62 [0.99-2.67],0.0556194845765251
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19986,52,3.12 [1.68-5.79],0.000324477529784
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza,17906,130,1.72 [1.01-2.93],0.0474276865357279
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17903,127,1.80 [1.06-3.07],0.0294711511841652
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12506,87,0.65 [0.30-1.40],0.271503001793634
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,20073,206,1.02 [0.64-1.65],0.9268000674341716
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13608,1514,0.96 [0.80-1.15],0.6706996564063297
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13914,1495,0.96 [0.80-1.15],0.6265987328358084
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19714,155,1.75 [1.08-2.84],0.0239456685039349
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17863,87,2.56 [1.54-4.28],0.0003164595292809
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bronchiectasis,16879,446,1.17 [0.85-1.61],0.3224729901683493
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16496,63,1.19 [0.52-2.75],0.6826166069402266
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19180,2747,0.99 [0.87-1.13],0.937049620218498
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19099,68,2.11 [1.07-4.17],0.0311507842778901
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,19148,117,1.82 [1.04-3.17],0.0347096669914473
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19907,1393,1.07 [0.89-1.28],0.4681929069654877
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,19103,72,1.24 [0.57-2.71],0.5920871870621592
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18293,5252,1.24 [1.13-1.36],7.482898261017324e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19328,297,1.01 [0.68-1.49],0.9767143975636792
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Early onset COPD,18615,101,1.08 [0.57-2.06],0.8082446926283712
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Emphysema,16815,382,1.49 [1.09-2.04],0.011340001041793
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19009,409,2.56 [2.04-3.21],3.968777029883992e-16
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19935,2159,1.53 [1.34-1.75],5.150493775616461e-10
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,19046,446,2.43 [1.93-3.05],3.3682557003393195e-14
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Later onset COPD,19696,1292,1.07 [0.89-1.29],0.4891709092539336
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20144,390,1.09 [0.78-1.54],0.6017991850171842
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Nasal polyp,19118,87,0.96 [0.46-2.00],0.9113392486464538
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19915,1085,1.53 [1.26-1.85],1.441380223620302e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,19911,2292,1.42 [1.24-1.63],4.138539155286564e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19688,657,1.11 [0.85-1.45],0.4298105153663816
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other pleural conditions,17674,55,1.63 [0.69-3.82],0.2626012046171148
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20043,526,2.30 [1.84-2.87],2.087471448575429e-13
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20045,1480,1.33 [1.12-1.58],0.0012551289193735
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural effusion,18747,1128,1.29 [1.05-1.57],0.0141564523557456
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural plaque,17843,224,1.58 [1.04-2.41],0.0314980004277269
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19689,1913,1.55 [1.35-1.79],1.587528404238929e-09
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20046,292,1.13 [0.76-1.67],0.5520797927957595
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumothorax,17772,153,0.66 [0.37-1.16],0.1483534762930724
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pollen allergy,20151,173,1.09 [0.65-1.83],0.7393648103580581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,19595,78,2.37 [1.32-4.27],0.0039227175039459
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12479,60,3.07 [1.34-7.05],0.0080132576682019
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19899,1069,1.54 [1.27-1.87],1.0695582636979632e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19238,207,1.03 [0.64-1.66],0.8875198027296125
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Viral pneumonia,18026,250,1.44 [0.97-2.15],0.0736296068263087
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19723,199,1.19 [0.75-1.90],0.4581277787477763
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6507,103,1.04 [0.53-2.03],0.9053767110666384
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12902,53,0.76 [0.29-1.96],0.5669363059735537
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute appendicitis,20057,112,0.73 [0.38-1.41],0.3449628002139199
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute gastritis,14101,84,0.78 [0.37-1.66],0.5193374804497045
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,18426,167,1.10 [0.65-1.85],0.7254717067159089
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute peritonitis,19748,93,1.50 [0.78-2.88],0.2237103698185439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19314,53,3.54 [2.10-5.98],2.2972770554179e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,14449,432,0.79 [0.57-1.11],0.1762450803084882
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18386,127,0.81 [0.44-1.48],0.4914872695830802
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19799,127,0.79 [0.43-1.46],0.4522254835124643
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholecystitis,18445,186,1.30 [0.81-2.10],0.2810261611706275
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholelithiasis,19160,901,1.10 [0.88-1.37],0.4223198301996689
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic gastritis,14311,294,0.82 [0.55-1.24],0.3472449059571124
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18306,47,1.76 [0.73-4.26],0.2115668880496558
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20042,111,1.84 [1.06-3.19],0.0298384378240095
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Coeliac disease,18675,108,0.95 [0.48-1.85],0.8698642536002078
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Collagenous colitis,18644,88,1.56 [0.78-3.10],0.2067768411377904
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20057,147,1.08 [0.62-1.88],0.775511704883554
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Constipation,19913,1770,1.01 [0.86-1.19],0.9229887726828582
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn disease,18626,70,1.37 [0.63-2.99],0.4243871444361615
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19854,54,1.50 [0.63-3.59],0.3622228628816385
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18620,64,1.61 [0.74-3.50],0.2332691296583099
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Dental caries,19625,161,0.96 [0.56-1.63],0.8676686636778104
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17457,2202,1.01 [0.87-1.17],0.9303264716919288
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of appendix,20083,138,0.86 [0.48-1.55],0.621986206161397
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of liver,20060,799,1.26 [1.00-1.59],0.0515926970059991
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17968,3951,1.08 [0.97-1.20],0.1859716875509293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19870,406,1.07 [0.76-1.49],0.7035010288013412
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20086,431,1.06 [0.77-1.47],0.725324534409834
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19544,80,1.72 [0.87-3.41],0.117388286874518
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19437,47,0.99 [0.36-2.68],0.981668948789518
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19884,1317,1.19 [0.99-1.43],0.0613142346545209
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of tongue,19447,81,0.72 [0.33-1.56],0.4056770007185034
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19565,1306,1.07 [0.89-1.29],0.487234277787149
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16137,3288,0.86 [0.76-0.97],0.0143923191284007
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,14219,202,1.16 [0.72-1.88],0.532550716610039
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20074,163,1.20 [0.72-2.02],0.4847477857801945
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20131,20,1.03 [0.22-4.79],0.9711666624750368
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19390,129,1.69 [1.00-2.86],0.0496927228871409
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12947,98,1.55 [0.82-2.92],0.1764675956328138
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,14503,486,0.93 [0.68-1.28],0.6656559634003704
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastric ulcer,14376,359,1.26 [0.88-1.79],0.2053913834056223
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16307,2290,1.06 [0.92-1.22],0.4459652070002277
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14561,544,1.20 [0.89-1.60],0.2271906615936706
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14645,7132,1.03 [0.95-1.12],0.4435101100261641
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,GI-bleeding,19649,1082,1.30 [1.06-1.58],0.0103162462861422
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19509,45,0.94 [0.35-2.54],0.910147788668448
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13712,1030,1.05 [0.85-1.29],0.6816189722614369
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19321,60,1.92 [0.92-4.00],0.0823920940304162
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Hernia,18384,3129,0.95 [0.84-1.08],0.456649671898893
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impacted teeth,20133,19,1.35 [0.30-6.15],0.7004475721383908
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impaction of intestines,12915,66,0.98 [0.42-2.32],0.9720540629124867
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Inguinal hernia,16198,943,0.85 [0.68-1.07],0.162881083002066
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15357,102,0.62 [0.31-1.23],0.1703596101623542
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12949,100,1.46 [0.77-2.77],0.2515743864183672
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18694,127,0.97 [0.52-1.80],0.928209397998068
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13290,441,1.02 [0.73-1.42],0.905238174532027
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20136,287,1.01 [0.68-1.49],0.9719746957267856
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19233,677,1.31 [1.02-1.69],0.0342347314466171
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19499,943,1.40 [1.13-1.73],0.0018968498160756
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,14205,188,1.00 [0.61-1.66],0.98602505747684
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophagitis,14626,609,1.35 [1.03-1.76],0.0305013199689882
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20109,118,1.81 [1.05-3.14],0.0339512010927812
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15327,72,1.04 [0.46-2.34],0.9188532419380542
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14041,1192,1.03 [0.84-1.25],0.8023139124582012
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18566,307,0.99 [0.67-1.47],0.9781140203025928
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18384,125,0.78 [0.42-1.46],0.4423836055174694
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,14520,1671,0.89 [0.75-1.06],0.1939529916666387
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,18167,5318,0.98 [0.89-1.07],0.6071108250750177
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19416,186,1.30 [0.80-2.10],0.2904398000881623
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of liver,19922,661,1.20 [0.93-1.55],0.1707309116112476
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14680,663,0.92 [0.70-1.20],0.5210901530832622
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18436,177,1.00 [0.60-1.66],0.9946485454966472
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20021,366,1.02 [0.72-1.46],0.8990927478572421
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14956,939,1.11 [0.89-1.39],0.3476937940134975
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19661,1094,1.29 [1.06-1.57],0.0120556306337486
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19616,152,0.76 [0.44-1.34],0.3476560278851319
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14657,1808,0.99 [0.84-1.16],0.860941585433215
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15884,1867,1.08 [0.92-1.27],0.3337752775358499
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19360,99,1.46 [0.78-2.73],0.2358033542912198
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19392,836,1.42 [1.14-1.78],0.0020785035529015
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13225,376,1.36 [0.97-1.90],0.0712740328911404
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20128,24,0.93 [0.22-3.83],0.9181996735210776
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13377,528,1.24 [0.93-1.66],0.1445040095979809
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18709,142,0.83 [0.46-1.48],0.5235073503235823
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20148,45,1.82 [0.74-4.47],0.1884805682368603
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19459,88,1.30 [0.64-2.65],0.4646412258848783
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Toxic colitis,18628,72,2.37 [1.30-4.34],0.0051372756352403
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14314,297,0.98 [0.66-1.46],0.931061068773152
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,18700,144,1.13 [0.64-1.99],0.6681236722750306
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18672,116,1.64 [0.91-2.95],0.1004230580696613
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Umbilical hernia,15479,224,0.56 [0.36-0.89],0.0142178269647523
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,13055,206,1.04 [0.65-1.68],0.868323994562901
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ventral hernia,15488,233,1.50 [0.98-2.29],0.0634307138496018
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Volvulus,12927,78,0.86 [0.39-1.89],0.7054434216645016
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20072,357,1.41 [1.00-1.99],0.0488923275180403
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19848,60,1.63 [0.72-3.70],0.2443956977262944
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17995,145,1.45 [0.84-2.51],0.1861356165785229
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19620,703,1.47 [1.15-1.88],0.0019374032766224
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19040,123,1.91 [1.12-3.26],0.0182267988647609
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18359,509,1.98 [1.54-2.54],6.94360072422823e-08
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19858,273,1.39 [0.94-2.05],0.0999433037609871
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20064,479,1.24 [0.92-1.68],0.1595684619713712
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19629,44,0.69 [0.24-1.99],0.4963567844341525
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18772,3191,1.34 [1.19-1.51],9.306298007458068e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19781,373,1.06 [0.74-1.50],0.7613870357584601
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19665,257,0.89 [0.58-1.36],0.5910236126245285
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19828,911,1.63 [1.33-2.01],3.858350949077169e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20143,51,1.57 [0.64-3.89],0.3250771517668511
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17905,55,0.60 [0.34-1.05],0.0752962868780245
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19463,55,2.02 [0.96-4.25],0.0632845440546422
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19846,261,1.44 [0.97-2.14],0.0702386573362729
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18366,516,1.19 [0.89-1.61],0.2427378752355724
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17930,80,1.93 [1.03-3.59],0.0390747980599611
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20087,74,1.64 [0.80-3.34],0.1761827278080785
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19100,183,2.01 [1.31-3.08],0.001442247069121
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19983,195,1.43 [0.90-2.27],0.1325743765298882
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19662,77,1.55 [0.77-3.15],0.2219649003196932
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17914,64,0.53 [0.22-1.27],0.1570253583301545
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19632,1782,1.49 [1.28-1.73],1.95142635601672e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18403,553,1.23 [0.92-1.63],0.1561398967204605
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17933,83,1.72 [0.89-3.31],0.1036542055824719
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20082,294,1.52 [1.04-2.21],0.0285303030193126
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19651,66,1.50 [0.69-3.25],0.301125415183703
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,20030,242,1.50 [0.99-2.26],0.0570925535716835
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20099,384,1.43 [1.03-1.99],0.0341458665184687
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17958,108,1.81 [0.99-3.29],0.0535756366190419
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18138,288,1.31 [0.88-1.95],0.186970862850015
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20088,373,1.38 [0.98-1.93],0.0629804675373406
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18123,273,2.76 [2.12-3.60],4.271012110936183e-14
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20136,123,1.64 [0.94-2.86],0.0824686109031012
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16836,69,1.11 [0.50-2.47],0.8020259883778829
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17792,5555,1.06 [0.96-1.16],0.234554262358355
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16567,4330,1.02 [0.92-1.14],0.6644345583494695
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16813,46,2.31 [1.01-5.28],0.0461668105942915
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16792,120,1.83 [1.07-3.15],0.0283174672291984
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16834,162,1.55 [0.94-2.55],0.0847577901603275
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19940,52,2.72 [1.43-5.17],0.0022914911221652
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16798,126,1.61 [0.93-2.78],0.0888457405199898
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13517,1280,1.17 [0.96-1.41],0.114348479642958
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19970,215,0.73 [0.46-1.18],0.2060336789945791
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17156,484,1.27 [0.94-1.72],0.1126469946902393
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16343,6952,1.14 [1.05-1.23],0.0025550648884316
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17993,105,1.39 [0.74-2.62],0.3111430620971314
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16919,152,1.12 [0.65-1.93],0.6788129951579367
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17210,443,1.22 [0.89-1.68],0.2191027348162104
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19343,2671,1.13 [1.00-1.29],0.0586375012197396
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17039,272,1.20 [0.79-1.81],0.3881535561357194
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16893,126,1.06 [0.58-1.95],0.8477695400954883
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16870,103,1.08 [0.55-2.12],0.8164106988868398
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19488,88,0.80 [0.38-1.68],0.5505171772928479
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13966,1729,1.02 [0.86-1.20],0.8158441248770433
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12892,655,1.21 [0.93-1.57],0.1657326204366664
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20078,649,1.09 [0.84-1.41],0.5045052196078395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12301,64,1.48 [0.64-3.40],0.3581666645200051
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12507,270,1.05 [0.69-1.60],0.8119256978403999
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16994,227,0.73 [0.46-1.15],0.1761613028303668
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12655,418,0.69 [0.49-0.98],0.0365789834565045
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16739,67,1.97 [0.98-3.97],0.0567405146707587
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17247,575,1.25 [0.95-1.64],0.1173680449664438
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16931,259,0.71 [0.46-1.10],0.1234031004487579
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12628,391,0.75 [0.52-1.06],0.1039464954371608
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16828,61,0.52 [0.21-1.30],0.1616648649635764
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16815,48,1.46 [0.57-3.69],0.4276720997732575
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17955,67,1.44 [0.66-3.15],0.3554225960301681
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19790,1902,1.07 [0.92-1.25],0.3924483415108172
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19232,1344,1.15 [0.95-1.38],0.1445695141621781
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20018,467,1.28 [0.94-1.73],0.1127600227411672
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14941,2704,1.14 [1.00-1.30],0.0516035143266069
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12277,40,0.40 [0.13-1.23],0.1108317342894638
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16854,87,1.59 [0.81-3.14],0.1804154227288876
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12303,66,2.14 [0.99-4.61],0.0520519508136319
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12354,117,1.51 [0.83-2.77],0.1769499592305228
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,18094,206,1.07 [0.67-1.72],0.7637122314140186
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,18305,417,1.05 [0.75-1.47],0.7595857015043909
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20143,93,2.04 [1.14-3.67],0.0170680860685028
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18356,1684,1.13 [0.96-1.33],0.1372502488023589
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16828,61,0.86 [0.36-2.09],0.7434720387099867
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12368,131,1.25 [0.68-2.28],0.4689774056187112
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17345,673,0.86 [0.66-1.12],0.2570853915831804
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,14115,1878,1.12 [0.96-1.31],0.1533852348520382
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19508,108,0.88 [0.45-1.71],0.6977885483173646
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20153,57,1.69 [0.75-3.82],0.204611754861498
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16836,69,1.24 [0.56-2.75],0.5909150322035878
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17907,1140,1.18 [0.96-1.43],0.1094382857766683
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16855,88,1.33 [0.66-2.68],0.4239251739539921
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14032,1795,1.03 [0.87-1.21],0.7490407404655803
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17991,103,0.67 [0.34-1.34],0.261173744894145
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16795,28,0.50 [0.13-1.90],0.3073375442584704
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16842,170,0.91 [0.54-1.56],0.7410849242364328
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17338,571,1.26 [0.96-1.67],0.100449288531176
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19830,430,0.73 [0.52-1.02],0.0625690565167126
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17229,557,1.32 [1.00-1.74],0.0523092222353481
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20029,462,1.30 [0.96-1.77],0.087532729141972
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20139,57,1.00 [0.40-2.47],0.9973287801149284
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16908,141,1.28 [0.73-2.24],0.3843148819069454
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15721,745,1.17 [0.91-1.49],0.2149766417378212
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17309,542,1.18 [0.89-1.57],0.2563605001997383
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17012,245,1.22 [0.79-1.88],0.376666342457793
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12303,66,0.71 [0.29-1.71],0.4409695622883949
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14927,2690,1.12 [0.98-1.28],0.0853172207992564
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12955,718,1.01 [0.78-1.31],0.946700057617644
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19721,321,0.79 [0.53-1.16],0.2261119817154695
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20113,63,2.10 [1.04-4.22],0.0373582443121079
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17876,58,0.76 [0.31-1.86],0.5473644639642716
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12295,58,1.85 [0.82-4.19],0.139607427925616
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16766,94,1.11 [0.55-2.23],0.7793792204724193
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12711,474,1.32 [0.98-1.79],0.0722044486174461
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17060,293,0.80 [0.53-1.19],0.264735683396143
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16915,243,0.96 [0.62-1.49],0.855464970164088
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16895,223,1.24 [0.80-1.94],0.3354649120208173
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,14231,60,2.00 [0.96-4.17],0.0632755580134129
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20143,61,1.20 [0.51-2.84],0.6705043646969693
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17246,479,0.98 [0.72-1.34],0.9152476393355
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19487,87,0.47 [0.22-1.01],0.0536761052952858
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19022,2255,1.12 [0.97-1.29],0.1267897323065067
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16895,128,0.98 [0.53-1.80],0.93977468380078
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17257,585,1.13 [0.86-1.50],0.3760177098988161
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18957,231,1.16 [0.74-1.80],0.5213281340599445
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16876,204,1.15 [0.72-1.84],0.5642879213417539
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18351,1679,1.13 [0.96-1.33],0.1500675978275427
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17768,1096,1.26 [1.03-1.54],0.02432258103261
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16816,49,2.77 [1.36-5.66],0.0050681436953116
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19510,110,0.84 [0.43-1.62],0.599201786956702
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16915,148,1.61 [0.95-2.72],0.0741230990310307
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16849,82,1.01 [0.47-2.16],0.9889341174004442
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12299,62,1.56 [0.68-3.59],0.2934461739883569
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19011,1832,1.37 [1.18-1.60],2.943282503805421e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),8116,23,1.67 [0.42-6.70],0.4682709546101228
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10313,27,0.85 [0.22-3.27],0.8093787285828267
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19882,269,0.78 [0.51-1.18],0.2420553339529106
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19703,90,0.93 [0.46-1.90],0.8482943128300926
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18939,1760,1.19 [1.01-1.39],0.0328474227545998
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19977,89,1.26 [0.64-2.47],0.5034131688802748
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19932,339,1.32 [0.93-1.88],0.1171145365102881
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cystitis,16926,262,1.08 [0.71-1.64],0.7242137196808676
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Dialysis,17247,68,1.19 [0.54-2.64],0.6610234522689946
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8837,1834,0.98 [0.84-1.15],0.8247992774173165
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10395,109,1.23 [0.66-2.31],0.5155641371189859
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,8128,35,1.57 [0.50-4.92],0.4391413067253067
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8592,499,1.17 [0.86-1.60],0.3246764473356096
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16651,5341,1.11 [1.01-1.21],0.0326055199719819
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19957,69,1.39 [0.66-2.96],0.3899354013682361
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,7108,105,0.79 [0.41-1.54],0.4886765013551294
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17205,279,0.95 [0.63-1.43],0.7952967668127814
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8561,1558,0.96 [0.81-1.14],0.6272010987795333
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10451,138,0.89 [0.49-1.60],0.6866025775687203
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),7109,106,1.40 [0.74-2.64],0.2987174086504114
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16736,72,1.18 [0.54-2.59],0.6842292599946196
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8989,896,1.08 [0.86-1.36],0.5160252518738369
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7052,49,1.53 [0.62-3.75],0.3551508597509468
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,8127,34,3.00 [1.13-8.00],0.0279248103609183
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20154,75,1.16 [0.53-2.53],0.7064378585864641
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20149,75,1.19 [0.55-2.57],0.6593897799514903
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19129,2465,1.14 [1.00-1.31],0.0541188959644755
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17480,816,0.95 [0.74-1.20],0.6509799172040996
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10330,44,2.57 [1.20-5.49],0.0148234195074747
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20098,505,1.13 [0.84-1.53],0.4009800458481795
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,7127,124,0.69 [0.37-1.27],0.2362164577635823
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,7141,138,1.04 [0.59-1.83],0.8983736052998116
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,7131,128,0.78 [0.43-1.43],0.421639147046784
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20128,69,0.82 [0.35-1.89],0.6379735887220921
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18581,1917,1.31 [1.13-1.52],0.0003881761673266
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10386,73,0.71 [0.31-1.61],0.4064072181671129
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8157,64,2.34 [1.09-5.01],0.0286957648185244
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8230,137,0.56 [0.30-1.03],0.0614535770594858
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8143,50,0.80 [0.29-2.20],0.6604349990261087
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8182,89,0.50 [0.23-1.08],0.0778948171289956
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17255,329,1.08 [0.75-1.57],0.6746690351002036
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19757,164,0.84 [0.49-1.43],0.517544166587729
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8199,106,1.02 [0.52-2.03],0.9436899406236152
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,8115,22,1.58 [0.39-6.51],0.523895645822633
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8283,190,1.14 [0.69-1.88],0.6143504501280577
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8176,83,0.85 [0.39-1.87],0.6872462997040474
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8278,185,1.09 [0.66-1.81],0.7399127397074857
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19935,47,0.64 [0.23-1.74],0.3829078247328027
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",7135,132,1.04 [0.58-1.86],0.8853279154885265
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19952,3026,1.19 [1.06-1.34],0.0045061115566315
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17002,76,0.84 [0.38-1.88],0.6784149330295531
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17318,139,1.74 [1.05-2.86],0.0308471583529623
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19647,34,0.39 [0.12-1.27],0.1193954943546167
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16892,228,1.02 [0.65-1.60],0.9371764108419582
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19959,346,0.80 [0.55-1.15],0.2272078509226859
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,8127,34,2.01 [0.68-5.96],0.2075578781926383
